Skip to content
DaisukeKotani· @DaisukeKotani · X·· 2 days agoScore70

HOPE-001

Body

#ESMO26
G-HOPE-001
@myESMO @OncoAlert

914 views · 15 likes · 5 reposts · 0 replies

Conference abstracts
LBA77matched by Proffered paper 1: Gastrointestinal tumour, upper digestive

Arcotatug tavatecan (IBI343/TAK-921) versus treatment of physician’s choice (TPC) in previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA): First interim analysis of the randomized, open-label, phase 3, G

https://esmocongress.esmo.org
引用@
#ESMO26 | LBA77 G-HOPE-001: Ph3 Arcotatug tavatecan (CLDN-ADC) vs SoC in 3L+ CLDN18.2+ GEA ▪️PFS: 5.5 vs 2.9 mo, HR 0.47, p<0.0001 ▪️OS: 9.9 vs 7.4 mo, HR 0.63 ▪️ORR: 23.6% vs 5.3% @myESMO @OncoAlert
在 X 查看被引用的帖子

Source: DaisukeKotani · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org